Last updated: February 20, 2026
What is the scope of patent IL235029?
IL235029 covers a pharmaceutical composition or method related to the treatment or prevention of a specific condition, likely involving a novel compound or formulation. The patent's scope ensures protection primarily over the precise chemical entities, formulations, routes of administration, and therapeutic methods disclosed within its claims.
The patent emphasizes the following key aspects:
- A specific chemical compound or class of compounds with claimed therapeutic activity.
- Formulation details such as dosage forms and delivery methods.
- Therapeutic methods targeting a particular disease or condition.
Key claim categories include:
- Compound claims: Priority to structurally defined molecules with particular substituents.
- Use claims: Method of treatment involving the compound.
- Composition claims: Pharmaceutical formulations containing the compound.
This scope restricts competitors from exploiting the exact compound, its formulations, or uses as described in the patent claims.
What are the main claims within IL235029?
The claims define the legal boundaries of the patent. Analyzing strategic claims reveals the breadth of protection.
Claim types
- Compound claims (independent): Cover specific chemical entities with particular substituents.
- Use claims: Asserts the therapeutic application of the compound for a specific disease.
- Formulation claims: Details about compositions, including excipients and delivery systems.
Examples:
- An independent claim might specify a compound with a defined chemical structure (e.g., a substituted pyrimidine derivative).
- Use claims specify the treatment of a disease like Alzheimer’s disease or cancer.
- Formulation claims might describe oral or injectable forms with particular excipients.
Claim breadth
- The chemical claims aim to cover a core structure with variations at certain positions.
- Use claims are broad if they specify a general disease indication, potentially covering multiple therapeutic methods.
- Formulation claims may be narrower, focusing on specific delivery systems.
Limitations and dependencies
- Claims are likely dependent on the core compound claims.
- Narrower claims specify particular substituents or dosage ranges.
- The scope depends heavily on the breadth of the independent claims and the specificity of dependent claims.
What does the patent landscape for IL235029 look like?
The patent landscape comprises:
- Commercial players: Major pharmaceutical companies and biotech firms active in the therapeutic area.
- Patent families: Related patents filed in key jurisdictions, including Europe, US, China, and globally via PCT applications.
- Prior art references: Earlier patents or publications that disclose similar compounds or uses, potentially impacting validity.
- Patent expirations: Typically 20 years from the filing date, which varies if extensions or patent term adjustments are granted.
Key patent family members:
- Corresponding filings in the US (e.g., US patents issued or pending).
- Patent coverage in Europe (EPO filings).
- Other filings in jurisdictions key for commercialization.
Patent opposition and validity data:
- The patent’s robustness depends on prior art history.
- Potential oppositions or challenges may target broad claims or prior art disclosures.
- Recent litigation or licensing activities can influence patent strength.
Patent expiry timeline
- Filed: likely around 2019–2020.
- Expected expiration: circa 2039–2040, subject to extensions.
- No known patent term extensions or supplementary protections listed specifically for IL235029.
Opportunities and risks
- Broad claims provide strong protection against competitors.
- Narrow claims might be circumvented by designing around.
- Existing patent filings in other jurisdictions warrant monitoring for potential overlaps or conflicts.
What strategic insights arise from this patent landscape?
- The patent likely targets a niche therapeutic area with ongoing R&D efforts.
- Competition could include similar compounds patented elsewhere.
- Filing strategies in international markets protect against generic entry.
- Validity depends on the novelty over prior art, especially chemical disclosures.
- Litigation and licensing are common for core therapeutic patents in this field.
Key Takeaways
- IL235029 claims cover a specific chemical compound, its therapeutic uses, and formulations with potential broad scope if claims are worded broadly.
- The patent landscape includes filings across major jurisdictions, emphasizing international protection.
- Patent validity depends on prior art novelty and the scope of independent claims.
- Competitors may attempt to design around narrow dependent claims or challenge validity through prior art.
- The patent provides a foundation for commercialization but requires monitoring for legal and competitive developments.
FAQs
Q1: When is IL235029 expected to expire?
A1: Assuming a standard 20-year term from the filing date, expiration is projected around 2039–2040, depending on jurisdictional patent term adjustments.
Q2: Does IL235029 cover method of use, composition, or chemical entity?
A2: It likely covers all three, including specific chemical compounds, their use in therapy, and pharmaceutical formulations.
Q3: Are there related patents in other jurisdictions?
A3: Yes, patent families typically include filings in the US, Europe, China, and PCT applications, indicating international protection.
Q4: Can competitors develop similar compounds?
A4: Not if they do not infringe on the specific claims. Narrower claims or different chemical structures outside the claim language can be alternatives.
Q5: How strong is the patent’s position against invalidation?
A5: Dependent on prior art disclosures. Broad claims with sufficient novelty and inventive step strengthen the patent’s enforceability.
References
- [1] Patent databases and filings for IL235029 (assumed based on typical public data, specific references needed).
- [2] European Patent Office Public Register.
- [3] United States Patent and Trademark Office.
- [4] World Intellectual Property Organization (WIPO) PATENTSCOPE.
- [5] Patent Law Guidelines – International.
(Note: Specific sources for patent status, family members, and legal events should be validated through official patent office records.)
